← Eichor · All briefs

NCT03239392 — LGL Leukemia trial site landscape

Public-registry site landscape for NCT03239392, a LGL Leukemia study sponsored by Bioniz Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT03239392 (registry record)
SponsorBioniz Therapeutics
Condition(s)LGL Leukemia; CTCL
PhasePHASE1 / PHASE2
Listed sites4
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03239392 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.